Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application

Cell-based immunotherapy holds promise in the quest for the treatment of cancer, having potential synergy with surgery, chemotherapy and radiotherapy. As a novel approach for adoptive cell-based immunotherapy, cytokine-induced killer (CIK) cells have moved from the ‘bench to bedside’. CIK cells are...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yiming Meng, Zhifu Yu, Yefeng Wu, Tianzhao Du, Shi Chen, Fanjuan Meng, Nan Su, Yushu Ma, Xiaoxi Li, Sulan Sun, Guirong Zhang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2017-06-01
סדרה:	Human Vaccines & Immunotherapeutics
נושאים:	cytokine-induced killer cells cytotoxicity contamination quality control tumor immunotherapy therapy
גישה מקוונת:	http://dx.doi.org/10.1080/21645515.2017.1285987
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!